Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1511702
                    [Title] => Planner 5D – Home Design
                    [Summary] => 
The “Planner 5D – Home Design” app allows electronic consumers to create virtual mockups of home interiors and designs without having to spend countless hours learning how to render 2-dimensional or 3-dimensional virtualizations using specialized software.

                    [DatePublished] => 2015-10-16 10:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1794253
                    [AuthorName] => Yasunari Ramon Suarez Taguchi
                    [SectionName] => Freeman Cebu Lifestyle
                    [SectionUrl] => cebu-lifestyle
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 495307
                    [Title] => Microsoft ordered to pay $290 million in patent ruling
                    [Summary] => 
SEATTLE (AP) -- A federal judge in Texas has ordered Microsoft Corp. to stop selling some versions of its Word software in the US within two months.
                    [DatePublished] => 2009-08-13 10:33:38
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 184159
                    [Title] => US court upholds patent for drug
                    [Summary] => A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make cheaper versions of the drug.


A Financial Times report from New York said a district court in Delaware ruled against Teva Pharmaceuticals and Ivas Pharmaceutical, two Israeli companies which were attempting to launch inexpensive versions of Fosomax. Merck’s patent on the drug, which generated $455 million in sales last quarter, is valid until August 2007.


                    [DatePublished] => 2002-11-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

VERSIONS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1511702
                    [Title] => Planner 5D – Home Design
                    [Summary] => 
The “Planner 5D – Home Design” app allows electronic consumers to create virtual mockups of home interiors and designs without having to spend countless hours learning how to render 2-dimensional or 3-dimensional virtualizations using specialized software.

                    [DatePublished] => 2015-10-16 10:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1794253
                    [AuthorName] => Yasunari Ramon Suarez Taguchi
                    [SectionName] => Freeman Cebu Lifestyle
                    [SectionUrl] => cebu-lifestyle
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 495307
                    [Title] => Microsoft ordered to pay $290 million in patent ruling
                    [Summary] => 
SEATTLE (AP) -- A federal judge in Texas has ordered Microsoft Corp. to stop selling some versions of its Word software in the US within two months.
                    [DatePublished] => 2009-08-13 10:33:38
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 184159
                    [Title] => US court upholds patent for drug
                    [Summary] => A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make cheaper versions of the drug.


A Financial Times report from New York said a district court in Delaware ruled against Teva Pharmaceuticals and Ivas Pharmaceutical, two Israeli companies which were attempting to launch inexpensive versions of Fosomax. Merck’s patent on the drug, which generated $455 million in sales last quarter, is valid until August 2007.


                    [DatePublished] => 2002-11-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Planner 5D – Home Design

By Yasunari Ramon Suarez Taguchi | October 16, 2015 - 10:00am

The “Planner 5D – Home Design” app allows electronic consumers to create virtual mockups of home interiors and designs without having to spend countless hours learning how to render 2-dimensional...

Freeman Cebu Lifestyle

Microsoft ordered to pay $290 million in patent ruling

August 13, 2009 - 10:33am

SEATTLE (AP) -- A federal judge in Texas has ordered Microsoft Corp. to stop selling some versions of its Word software in the US within two months.

US court upholds patent for drug

November 16, 2002 - 12:00am

A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make...

Business